Original Articles
6 September 2023
Vol. 17 No. 2 (2023)
Identification of hub genes associated with hepatitis B virus-related hepatocellular cancer using weighted gene co-expression network analysis and protein-protein interaction network analysis
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
915
Views
393
Downloads
62
HTML
Authors
Background. Chronic hepatitis B virus (HBV) infection is the main pathogen of hepatocellular carcinoma. However, the mechanisms of HBV-related hepatocellular carcinoma (HCC) progression are practically unknown. Materials and Methods. The results of RNA-sequence and clinical data for GSE121248 and GSE17548 were accessed from the Gene Expression Omnibus data library. We screened Sangerbox 3.0 for differentially expressed genes (DEGs). The weighted gene co-expression network analysis (WGCNA) was employed to select core modules and hub genes, and protein-protein interaction network module analysis also played a significant part in it. Validation was performed using RNA-sequence data of cancer and normal tissues of HBV-related HCC patients in the cancer genome atlas-liver hepatocellular cancer database (TCGA-LIHC). Results. 787 DEGs were identified from GSE121248 and 772 DEGs were identified from GSE17548. WGCNA analysis indicated that black modules (99 genes) and grey modules (105 genes) were significantly associated with HBV-related HCC. Gene ontology analysis found that there is a direct correlation between DEGs and the regulation of cell movement and adhesion; the internal components and external packaging structure of plasma membrane; signaling receptor binding, calcium ion binding, etc. Kyoto Encyclopedia of Genes and Genomes pathway analysis found out the association between cytokine receptors, cytokine-cytokine receptor interactions, and viral protein interactions with cytokines were important and HBV-related HCC. Finally, we further validated 6 key genes including C7, EGR1, EGR3, FOS, FOSB, and prostaglandin-endoperoxide synthase 2 by using the TCGALIHC. Conclusions. We identified 6 hub genes as candidate biomarkers for HBV-related HCC. These hub genes may act as an essential part of HBV-related HCC progression.
Altmetrics
Downloads
Download data is not yet available.
Citations
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424. DOI: https://doi.org/10.3322/caac.21492
McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of Hepatocellular Carcinoma. Hepatology 2021;73:4-13. DOI: https://doi.org/10.1002/hep.31288
D’Souza S, Lau KC, Coffin CS, et al. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol 2020;26:5759-83. DOI: https://doi.org/10.3748/wjg.v26.i38.5759
Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 2018;67:358-80. DOI: https://doi.org/10.1002/hep.29086
Papatheodoridis GV, Sypsa V, Dalekos G, et al. Eightyear survival in chronic hepatitis B patients under longterm entecavir or tenofovir therapy is similar to the general population. J Hepatol 2018;68:1129-36. DOI: https://doi.org/10.1016/j.jhep.2018.01.031
Papatheodoridi M, Tampaki M, Lok AS, et al. Risk of HBV reactivation during therapies for HCC: A systematic review. Hepatology 2021. DOI: https://doi.org/10.1002/hep.32241
Bouvard V, Baan R, Straif K, et al. A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009;10:321-2. DOI: https://doi.org/10.1016/S1470-2045(09)70096-8
Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis 2010;30:3-16. DOI: https://doi.org/10.1055/s-0030-1247128
Yang JD, Ray Kim W, Coelho R, et al. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma. Clin Gastroenterol Hepatol 2011;9:64-70. DOI: https://doi.org/10.1016/j.cgh.2010.08.019
Xie Y. Hepatitis B Virus-Associated Hepatocellular Carcinoma. Adv Exp Med Biol 2017;1018:11-21. DOI: https://doi.org/10.1007/978-981-10-5765-6_2
Wang SM, Ooi LL, Hui KM. Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma. Clin Cancer Res 2007;13:6275-83. DOI: https://doi.org/10.1158/1078-0432.CCR-06-2236
Yildiz G, Arslan-Ergul A, Bagislar S, et al., Genome-wide transcriptional reorganization associated with senescence to-immortality switch during human hepatocellular carcinogenesis. PLoS One 2013;8:e64016. DOI: https://doi.org/10.1371/journal.pone.0064016
Clough E, Barrett T. The Gene Expression Omnibus Database. Methods Mol Biol, 2016;1418:93-110. DOI: https://doi.org/10.1007/978-1-4939-3578-9_5
Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008;9:559. DOI: https://doi.org/10.1186/1471-2105-9-559
Wang Z, Jensen MA, Zenklusen JC. A Practical Guide to The Cancer Genome Atlas (TCGA). Methods Mol Biol 2016;1418:111-41. DOI: https://doi.org/10.1007/978-1-4939-3578-9_6
Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol 2019;16:589-604. DOI: https://doi.org/10.1038/s41575-019-0186-y
Tang A, Hallouch O, Chernyak V, et al. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. Abdom Radiol (NY) 2018;43:13-25. DOI: https://doi.org/10.1007/s00261-017-1209-1
Chen Y, Tian Z. HBV-Induced Immune Imbalance in the Development of HCC. Front Immunol 2019;10:2048. DOI: https://doi.org/10.3389/fimmu.2019.02048
Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol 2016;64:S84-s101. DOI: https://doi.org/10.1016/j.jhep.2016.02.021
Venook AP, Papandreou C, Furuse J, et al. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010;15:5-13. DOI: https://doi.org/10.1634/theoncologist.2010-S4-05
Levrero M, Pollicino T, Petersen J, et al. Control of cccDNA function in hepatitis B virus infection. J Hepatol 2009;51:581-92. DOI: https://doi.org/10.1016/j.jhep.2009.05.022
Guerrieri F, Belloni L, Pediconi N, Levrero M. Molecular mechanisms of HBV-associated hepatocarcinogenesis. Semin Liver Dis 2013;33:147-56. DOI: https://doi.org/10.1055/s-0033-1345721
Merle NS, Noe R, Halbwachs-Mecarelli L, et al. Complement System Part II: Role in Immunity. Front Immunol 2015;6:257. DOI: https://doi.org/10.3389/fimmu.2015.00257
Seol HS, Lee SE, Song JS, et al. Complement proteins C7 and CFH control the stemness of liver cancer cells via LSF-1. Cancer Lett 2016;372:24-35. DOI: https://doi.org/10.1016/j.canlet.2015.12.005
Christy B, Nathans D. DNA binding site of the growth factor-inducible protein Zif268. Proc Natl Acad Sci USA 1989;86:8737-41. DOI: https://doi.org/10.1073/pnas.86.22.8737
Peng WX, Xiong E-M, Ge L, et al. Egr-1 promotes hypoxia-induced autophagy to enhance chemo-resistance of hepatocellular carcinoma cells. Exp Cell Res 2016;340: 62-70. DOI: https://doi.org/10.1016/j.yexcr.2015.12.006
Zhang Q, Song G, Yao L, et al. miR-3928v is induced by HBx via NF-κB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3. J Exp Clin Cancer Res 2018;37:14. DOI: https://doi.org/10.1186/s13046-018-0681-y
Tian H, Ge C, Li H, et al. Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma. Hepatology 2014;59:1459-70. DOI: https://doi.org/10.1002/hep.26929
Wang L, Sun H, Wang X, et al. EGR1 mediates miR- 203a suppress the hepatocellular carcinoma cells progression by targeting HOXD3 through EGFR signaling pathway. Oncotarget 2016;7:45302-45316. DOI: https://doi.org/10.18632/oncotarget.9605
Zhang S, Xia C, Xu C, et al. Early growth response 3 inhibits growth of hepatocellular carcinoma cells via upregulation of Fas ligand. Int J Oncol 2017;50:805-14. DOI: https://doi.org/10.3892/ijo.2017.3855
Wang ZD, Qu FY, Chen YY, et al. Involvement of microRNA- 718, a new regulator of EGR3, in regulation of malignant phenotype of HCC cells. J Zhejiang Univ Sci B 2017;18:27-36. DOI: https://doi.org/10.1631/jzus.B1600205
Fan Q, He M, Deng X, et al. Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma. Cell Biochem Funct 2013;31:319-24. DOI: https://doi.org/10.1002/cbf.2902
Güller M, Toualbi-Abed K, Legrand A, et al. c-Fos overexpression increases the proliferation of human hepatocytes by stabilizing nuclear Cyclin D1. World J Gastroenterol 2008;14:6339-46. DOI: https://doi.org/10.3748/wjg.14.6339
Bakiri L, Hamacher R, Graña O, et al. Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation. J Exp Med 2017;214:1387-409. DOI: https://doi.org/10.1084/jem.20160935
Sitalaksmi RM, Ito K, Ogasawara K, et al. COX-2 induces T cell accumulation and IFN-gamma production during the development of chromium allergy. Autoimmunity 2019;52:228-34. DOI: https://doi.org/10.1080/08916934.2019.1662404
Xia Y, Zhuo H, Lu Y, et al. Glycogen synthase kinase 3beta inhibition promotes human iTreg differentiation and suppressive function. Immunol Res 2015;62:60-70. DOI: https://doi.org/10.1007/s12026-015-8635-3
Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3:276-85. DOI: https://doi.org/10.1038/nrc1046
How to Cite
Identification of hub genes associated with hepatitis B virus-related hepatocellular cancer using weighted gene co-expression network analysis and protein-protein interaction network analysis. (2023). Italian Journal of Medicine, 17(2). https://doi.org/10.4081/itjm.2023.1626
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Roberto Nardi, Franco Berti, Antonio Greco, Giovanni Scanelli, Paolo Leandri, Massimo Reta, Magda Mazzetti, Angelo Pasquale, Gelorma Belmonte, Mirco Magnani, Stefania Frasson, Concetta Baldo, Gualberto Gussoni, Giorgio Vescovo, Micaela La Regina, Mauro Campanini, Ido Iori, Giovanni Mathieu, Antonino Mazzone, Carlo Nozzoli, Complexity in hospital internal medicine departments: what are we talking about? , Italian Journal of Medicine: Vol. 7 No. 3 (2013)
- Cecilia Politi, Tiziana Ciarambino, Letizia Riva, Stefania Frasson, Donata Lucci, Gualberto Gussoni, Lucio Gonzini, Mauro Campanini, Michele Gulizia, Giuseppe Di Pasquale, Giovanni Mathieu, on behalf of ATA-AF Steering Committee and Investigators, Sex-gender and atrial fibrillation treatment in the AntiThrombotic Agents in Atrial Fibrillation (ATA-AF) study , Italian Journal of Medicine: Vol. 10 No. 3 (2016)
- Giancarla Scalone, Giampaolo Niccoli, Filippo Crea, Pathophysiological aspects and management workflow of coronary microvascular obstruction in ST-segment elevation myocardial infarction , Italian Journal of Medicine: Vol. 10 No. 1 (2016)
- Roberto Nardi, Franco Berti, Leonardo M. Fabbri, Giuseppe Di Pasquale, Ido Iori, Giovanni Mathieu, Giorgio Vescovo, Andrea Fontanella, Antonino Mazzone, Mauro Campanini, Carlo Nozzoli, Dario Manfellotto, on behalf of the FADOI and their Friends in the FFA Project Group, Toward a sustainable and wise healthcare approach: potential contributions from hospital Internal Medicine Departments to reducing inappropriate medical spending , Italian Journal of Medicine: Vol. 7 No. 2 (2013)
- Ozturk Ates, Kemal Kosemehmetoglu, Gunes Guner, Yusuf Bayraktar, Primary amyloidosis presenting intrahepatic cholestasis and fulminant hepatic failure , Italian Journal of Medicine: Vol. 10 No. 1 (2016)
- Cecilia Politi, Tiziana Ciarambino, Flavia Franconi, Lucrezia De Feudis, Maria Carolina Mayer, Alessandra Martignoni, Ilaria Giovi, Michela Tonani, Salvatore La Carrubba, Anna Maria Moretti, Carmen Martino, Giovanni Scanelli, Gender medicine: an up-date , Italian Journal of Medicine: Vol. 7 No. 2 (2013)
- Vincenzo Nuzzo, Emanuela Foglia, Tiziana Attardo, Clelia Canale, Mariangela Di Lillo, Lorenzo Fiorin, Micaela La Regina, Ada Maffettone, Domenico Montemurro, Antonino Mazzone, for the Master Course in Clinical Governance, Clinical governance and internal medicine: a marriage of convenience? , Italian Journal of Medicine: Vol. 9 No. 2 (2015)
- Vitorino Modesto dos Santos, David Lima Pedrosa, Leonardo Abreu Soares Ferreira, Mariely Fernanda Silva Helbingen, An old woman with chronic palmar dermatosis, rheumatism, and nail changes , Italian Journal of Medicine: Vol. 11 No. 4 (2017)
- Filomena Pietrantonio, Laura Piasini, Federico Spandonaro, Internal medicine and emergency admissions: from a national hospital discharge records (SDO) study to a regional analysis , Italian Journal of Medicine: Vol. 10 No. 2 (2016)
- Agata Lax, Simona Colamartino, Paolo Banfi, Antonello Nicolini, Sleep-related breathing disorders and non-invasive ventilation , Italian Journal of Medicine: Vol. 9 No. 2 (2015)
You may also start an advanced similarity search for this article.